Chappard P, Pourchon F
Harm Reduct J. 2025; 22(1):23.
PMID: 39987212
PMC: 11847393.
DOI: 10.1186/s12954-025-01165-4.
Stopka T, Nance R, Mixson L, Spencer H, Tsui J, Leahy J
Trop Med Infect Dis. 2025; 10(1).
PMID: 39852668
PMC: 11769247.
DOI: 10.3390/tropicalmed10010017.
Manley H, Riback L, Nyakowa M, Akiyama M, Cherutich P, Lizcano J
PLOS Glob Public Health. 2025; 5(1):e0003284.
PMID: 39821143
PMC: 11737709.
DOI: 10.1371/journal.pgph.0003284.
Bowles J, Nyx E, Kalicum J, Kerr T
PLoS One. 2024; 19(12):e0315804.
PMID: 39739723
PMC: 11687812.
DOI: 10.1371/journal.pone.0315804.
Gonzalez M, Cardenas-Iniguez C, Linares D, Wonnum S, Bagot K, White E
Dev Cogn Neurosci. 2024; 71():101497.
PMID: 39724816
PMC: 11731755.
DOI: 10.1016/j.dcn.2024.101497.
Depoliticization of Violence: Critical Limits of Risk Environment Frameworks in Drug Use Research.
Kelsall T, McDermid J, Vieira E, Withers A, Tao V, Dives J
Inquiry. 2024; 61:469580241308442.
PMID: 39704344
PMC: 11662392.
DOI: 10.1177/00469580241308442.
Improving measures of context in process evaluations: development and use of the Context Tracker tool.
Busza J, Machingura F, Vuckovic C
Trials. 2024; 25(1):777.
PMID: 39558424
PMC: 11571973.
DOI: 10.1186/s13063-024-08623-7.
Characterizing people who inject drugs with no history of opioid agonist therapy uptake in Iran: Results from a national bio-behavioural surveillance survey in 2020.
Mehrabi F, Mehmandoost S, Mirzazadeh A, Noroozi A, Tavakoli F, Mirzaei H
Int J Ment Health Addict. 2024; 22(4):2378-2390.
PMID: 39493693
PMC: 11530214.
DOI: 10.1007/s11469-022-00992-x.
Structural Influences on Methamphetamine Use Among Black Sexual Minority Men (HISTORY Study): Protocol for a Longitudinal Cohort Study.
Opara S, Linton S, Weir B, Crawford N, Holland D, Newman Jr A
JMIR Res Protoc. 2024; 13:e63761.
PMID: 39481101
PMC: 11565090.
DOI: 10.2196/63761.
Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.
Mehmandoost S, Khezri M, Aghaali N, Shokoohi M, Haghdoost A, Tavakoli F
Harm Reduct J. 2024; 21(1):187.
PMID: 39425102
PMC: 11487831.
DOI: 10.1186/s12954-024-01107-6.
Examining the association between psychological resilience and chronic versus discrete stressors among individuals who use opioids in Baltimore, Maryland.
Sisson L, Tomko C, Rouhani S, Sherman S
Drug Alcohol Rev. 2024; 44(1):288-297.
PMID: 39420664
PMC: 11745933.
DOI: 10.1111/dar.13959.
Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment.
Barrios K, Connolly D, Ferris J, Maier L, Barratt M, Winstock A
J Psychopharmacol. 2024; 39(1):8-22.
PMID: 39420535
PMC: 11760648.
DOI: 10.1177/02698811241273850.
'You Can Die With Me But I Won't Let You Live With Me', Exploring Social Influences on the Continuation of Heroin Use in Men Who Use Heroin.
Houghton B, Kouimtsidis C, Duka T, Paloyelis Y, Bailey A, Notley C
Subst Use. 2024; 18:29768357241276320.
PMID: 39364208
PMC: 11447827.
DOI: 10.1177/29768357241276320.
Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.
Roux P, Faye A, Sagaon-Teyssier L, Donadille C, Briand Madrid L, Carrieri M
Drug Alcohol Rev. 2024; 44(1):275-287.
PMID: 39353607
PMC: 11743017.
DOI: 10.1111/dar.13955.
Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United States.
Romo E, Bianchet E, Dowd P, Mazor K, Stopka T, Friedmann P
Viruses. 2024; 16(9).
PMID: 39339841
PMC: 11605231.
DOI: 10.3390/v16091364.
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.
Walters S, Baker R, Frank D, Fadanelli M, Rudolph A, Zule W
Harm Reduct J. 2024; 21(1):154.
PMID: 39182116
PMC: 11344336.
DOI: 10.1186/s12954-024-01062-2.
Drug Overdose Death Following Substance Use Disorder Treatment Termination in New York City: A Retrospective Longitudinal Cohort Study.
Jordan A, Jette G, Graham J, Burke C, Cunningham C
J Urban Health. 2024; 101(5):1045-1057.
PMID: 39095494
PMC: 11461374.
DOI: 10.1007/s11524-024-00893-5.
"Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder.
Michener P, Bianchet E, Fox S, Evans E, Friedmann P
Harm Reduct J. 2024; 21(1):138.
PMID: 39034384
PMC: 11265078.
DOI: 10.1186/s12954-024-01055-1.
Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care.
Lopez-Castro T, Sohler N, Riback L, Bravo G, Ohlendorf E, Ghiroli M
Harm Reduct J. 2024; 21(1):108.
PMID: 38824597
PMC: 11143655.
DOI: 10.1186/s12954-024-01019-5.
A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand.
Whelan J, Ward R, Noller G
Harm Reduct J. 2024; 21(1):100.
PMID: 38783300
PMC: 11112856.
DOI: 10.1186/s12954-024-01024-8.